Results 211 to 220 of about 14,898,836 (369)

Effect of Foot Orthoses on Midfoot Pain and the Volume of Bone Marrow Lesions in the Midfoot: A Randomized Mechanism of Action Study

Arthritis Care &Research, EarlyView.
Objective Foot orthoses are thought to improve pain by potentially modifying internal mechanical forces. To test this, we explored whether foot orthoses can modify patterns of bone marrow lesions (BMLs) in people with midfoot pain. Methods Forty‐two people were recruited with midfoot pain, and magnetic resonance imaging–confirmed midfoot BMLs ...
Jill Halstead, Anne‐Maree Keenan, Philip G. Conaghan, Dennis McGonagle, Anthony C. Redmond   +4 more
wiley   +1 more source

miR-1270 suppresses glioblastoma development by transcriptional inhibition of nuclear factor IX. [PDF]

Mol Biol Rep
Wang Z, Lin J, Tan G, Pan T, Zhang H, Liu J.   +5 more
europepmc   +1 more source

Bisindolylmaleimide IX Facilitates Tumor Necrosis Factor Receptor Family-mediated Cell Death and Acts as an Inhibitor of Transcription [PDF]

, 2002
Oskar W. Rokhlin, Rebecca A. Glover, Agshin F. Taghiyev, Natalya V. Guseva, Richard E.B. Seftor, Inna Shyshynova, Andrei V. Gudkov, Michael B. Cohen   +7 more
openalex   +1 more source

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Proceedings of the National Academy of Sciences of the United States of America, 1977
Bjarne 0sterud, Samuel l. Rapaport, Bjarne 0sterud   +2 more
semanticscholar   +1 more source

Testing A Personalized Approach to Chronic Low Back Pain: A Randomized Controlled Trial in Older Veterans

Arthritis Care &Research, Accepted Article.
Objective We aimed to test the efficacy of personalized treatment of older Veterans with chronic low back pain (CLBP) delivered by Aging Back Clinics (ABC) as compared with usual care (UC). Methods Two hundred ninety‐nine Veterans age 65‐89 with CLBP from 3 VA medical centers underwent baseline testing, randomization to ABC or UC and 12 months follow ...
Debra K. Weiner, Angela Gentili, Meika A. Fang, Edward Garay, Laura Lawson, Lenore Joseph, Cathy C. Lee, Michelle I. Rossi, Beverly Thorn, Subashan Perera   +9 more
wiley   +1 more source

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX. [PDF]

J Clin Med
Park YS, Hwang TJ, Park SK, Choi EJ, Park JA, Baek HJ, Lyu CJ, Lee JH, Kim MK, Kim JY, Lee SA, Park B, Kim DH, Chung SB, Nam CM, Lee Y, Yoo KY.   +16 more
europepmc   +1 more source

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg- Calvé-Perthes Disease. [PDF]

Clin Appl Thromb Hemost, 2023
Hernández-Zamora E, Rodríguez-Olivas AO, Rosales-Cruz E, Galicia-Alvarado MA, Zavala-Hernández C, Reyes-Maldonado E.   +5 more
europepmc   +1 more source

The mechanism underlying activation of factor IX by factor XIa.

Thrombosis Research, 2014
D. Gailani, Yipeng Geng, I. Verhamme, Mao-fu Sun, S. P. Bajaj, A. Messer, J. Emsley   +6 more
semanticscholar   +1 more source

Clinical Conditions Associated With a High Antinuclear Antibody Titer in Individuals Without Autoimmune Disease

Arthritis Care &Research, EarlyView.
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung, John P. Shelley, Gul Karakoc, John Still, Xiaodi Ruan, Jonathan Mosley, C. Michael Stein, Vivian K. Kawai   +7 more
wiley   +1 more source

Prosthetic Mitral Valve Dehiscence Related to Infective Endocarditis and The Effect of Factor II, VII, IX, X (Cofakt ): Case Report

, 2013
Habib Çakır, Yüksel Beşir, İsmail Yürekli, Orhan Gökalp, Ersin Çelik, Kamil Aşar, Ali Gürbüz   +6 more
openalex   +1 more source